Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003871
Filing Date
2021-11-10
Accepted
2021-11-10 06:05:13
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20210930.htm   iXBRL 10-Q 2426925
2 EX-31.1 ikna-ex31_1.htm EX-31.1 19302
3 EX-31.2 ikna-ex31_2.htm EX-31.2 19381
4 EX-32.1 ikna-ex32_1.htm EX-32.1 19213
  Complete submission text file 0000950170-21-003871.txt   6699030

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ikna-20210930_def.xml EX-101.DEF 129301
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ikna-20210930_cal.xml EX-101.CAL 35526
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ikna-20210930.xsd EX-101.SCH 43142
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ikna-20210930_lab.xml EX-101.LAB 349768
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ikna-20210930_pre.xml EX-101.PRE 255046
10 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20210930_htm.xml XML 912325
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 211394243
SIC: 2836 Biological Products, (No Diagnostic Substances)